IntegraGen's IPO

IntegraGen raised a round of funding on June 16, 2010. Investors include Public.

IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests f…

Articles about IntegraGen's IPO: